Risk of Relapse after Anti-PD1 Discontinuation and Efficacy of Anti-PD1 Re-Treatment in Patients with Hodgkin Lymphoma

被引：4
|
作者：
Manson, Guillaume [1 ]
Brice, Pauline [2 ]
Herbaux, Charles [3 ]
Silva, Maria [4 ]
Bouabdallah, Krimo [5 ]
Deau-Fisher, Benedicte [6 ]
Bouteloup, Juliette [7 ]
de Collela, Jean Marc Schiano [8 ]
Nicolas-Virelizier, Emmanuelle [9 ]
Maerevoet, Marie [10 ]
Ghesquieres, Herve [11 ]
Bastard, Aspasia Stamatoulas [12 ]
Antier, Chloe [13 ]
Poizeau, Florence [14 ]
Dercle, Laurent [15 ]
Houot, Roch [16 ]
机构：
[1] Univ Hosp Rennes, Dept Hematol, Rennes, France
[2] Hop St Louis, Dept Hematol, Paris, France
[3] CHRU Lille, Lille, France
[4] Inst Portugues Oncol Lisboa, Dept Hematol, Lisbon, Portugal
[5] Univ Hosp Bordeaux, Dept Hematol, Pessac, France
[6] Cochin Hosp, Dept Hematol, Paris, France
[7] Chalon Ctr Hosp, Dept Hematol, Chalon Sur Saone, Saone & Loire, France
[8] Inst Paoli Calmettes, Marseille, France
[9] Leon Berard Ctr, Dept Hematol, Lyon, France
[10] Hosp Jules Bordet, Brussels, Belgium
[11] Hosp Civils Lyon, Dept Hematol, Ctr Hosp Lyon Sud, Pierre Benite, France
[12] Henri Becquerel Ctr, Rouen, France
[13] Nantes Univ Hosp, Dept Hematol, Nantes, France
[14] Rennes Univ Hosp, Dept Dermatol, Rennes, France
[15] Inst Gustave Roussy, Dept Med Imaging, Villejuif, France
[16] CHU Rennes, Dept Hematol, Rennes, France
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-122171
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1549
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantation
    Manson, Guillaume
    Mear, Jean-Baptiste
    Herbaux, Charles
    Schiano, Jean-Marc
    Casasnovas, Olivier
    Stamatoullas, Aspasia
    Deau, Benedicte
    Schmitt, Anna
    Garnier, Georges
    Regny, Caroline
    Bouabdallah, Krimo
    Moles-Moreau, Marie-Pierre
    Ghesquieres, Herve
    Tempescul, Adrian
    Dulery, Remy
    Nicolas-Virelizier, Emmanuelle
    Delmer, Alain
    Borel, Cecile
    Chauchet, Adrien
    Damotte, Diane
    Dercle, Laurent
    Brice, Pauline
    Houot, Roch
    EUROPEAN JOURNAL OF CANCER, 2019, 115 : 47 - 56
  • [32] Change of laboratory parameters during anti-PD1 treatment in patients with melanoma
    Janka, E. A.
    Vanyai, B.
    Varvolgyi, T.
    Remenyik, E.
    Emri, G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : S303 - S303
  • [33] Cordycepin Augments the Efficacy of Anti-PD1 against Colon Cancer
    Chang, Wen-Kuei
    Chen, Yen-Ting
    Lin, Chin-Ping
    Wang, Chia-Jung
    Shieh, Hui-Ru
    Chi, Chih-Wen
    Tsai, Tung-Hu
    Chen, Yu-Jen
    BIOMEDICINES, 2024, 12 (07)
  • [34] Targeting hyperactive tRNA modification improves anti-PD1 efficacy
    Eleni Kotsiliti
    Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 3 - 3
  • [35] Efficacy of anti-CTLA-4 after progression on anti-PD1 therapy in advanced melanoma
    Aya Moreno, F.
    Fernandez-Martinez, A.
    Gaba, L.
    Victoria, I.
    Arance Fernandez, A. M.
    ANNALS OF ONCOLOGY, 2015, 26 : 6 - 6
  • [36] Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas
    Toulemonde, E.
    Chevret, S.
    Battistella, M.
    Neidhardt, E. M.
    Nardin, C.
    Le Du, F.
    Meyer, N.
    Veron, M.
    Gambotti, L.
    Lamrani-Ghaouti, A.
    Jamme, P.
    Chaffaut, C.
    De Pontville, M.
    Saada-Bouzid, E.
    Beylot-Barry, M.
    Simon, C.
    Jouary, T.
    Marabelle, A.
    Mortier, L.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (08) : 2649 - 2657
  • [37] Targeting hyperactive tRNA modification improves anti-PD1 efficacy
    Kotsiliti, Eleni
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (01) : 3 - 3
  • [38] Treatment of Recurrent Primary Central Nervous System Lymphoma Patients with anti-PD1 Antibody Nivolumab
    Nayak, Lakshmi
    Iwamoto, Fabio
    NEUROLOGY, 2016, 86
  • [39] Functional binding of PD1 ligands predicts response to anti-PD1 treatment in patients with cancer
    Kaufman, Bar
    Abramov, Orli
    Ievko, Anna
    Apple, Daria
    Shlapobersky, Mark
    Allon, Irit
    Greenshpan, Yariv
    Bhattachrya, Baisali
    Cohen, Ofir
    Charkovsky, Tatiana
    Gayster, Alexandra
    Shaco-Levy, Ruthy
    Rouvinov, Keren
    Livoff, Alejandro
    Elkabets, Moshe
    Porgador, Angel
    SCIENCE ADVANCES, 2023, 9 (21)
  • [40] Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas
    E. Toulemonde
    S. Chevret
    M. Battistella
    E. M. Neidhardt
    C. Nardin
    F. Le Du
    N. Meyer
    M. Véron
    L. Gambotti
    A. Lamrani-Ghaouti
    P. Jamme
    C. Chaffaut
    M. De Pontville
    E. Saada-Bouzid
    M. Beylot-Barry
    C. Simon
    T. Jouary
    A. Marabelle
    L. Mortier
    Cancer Immunology, Immunotherapy, 2023, 72 : 2649 - 2657
12345